Development and in vitro evaluation of a liposome based implant formulation for the decapeptide cetrorelix
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Development and in vitro evaluation of a liposome based implant formulation for the decapeptide cetrorelix. / Grohganz, Holger; Tho, Ingunn; Brandl, Martin.
In: European Journal of Pharmaceutics and Biopharmaceutics, Vol. 59, No. 3, 2005, p. 439-448.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Grohganz, H, Tho, I & Brandl, M 2005, 'Development and in vitro evaluation of a liposome based implant formulation for the decapeptide cetrorelix', European Journal of Pharmaceutics and Biopharmaceutics, vol. 59, no. 3, pp. 439-448.
APA
Grohganz, H., Tho, I., & Brandl, M. (2005). Development and in vitro evaluation of a liposome based implant formulation for the decapeptide cetrorelix. European Journal of Pharmaceutics and Biopharmaceutics, 59(3), 439-448.
Vancouver
Grohganz H, Tho I, Brandl M. Development and in vitro evaluation of a liposome based implant formulation for the decapeptide cetrorelix. European Journal of Pharmaceutics and Biopharmaceutics. 2005;59(3):439-448.
Author
Bibtex
@article{7c271370f92711de825d000ea68e967b,
title = "Development and in vitro evaluation of a liposome based implant formulation for the decapeptide cetrorelix",
author = "Holger Grohganz and Ingunn Tho and Martin Brandl",
year = "2005",
language = "English",
volume = "59",
pages = "439--448",
journal = "European Journal of Pharmaceutics and Biopharmaceutics",
issn = "0939-6411",
publisher = "Elsevier",
number = "3",
}
RIS
TY - JOUR
T1 - Development and in vitro evaluation of a liposome based implant formulation for the decapeptide cetrorelix
AU - Grohganz, Holger
AU - Tho, Ingunn
AU - Brandl, Martin
PY - 2005
Y1 - 2005
M3 - Journal article
VL - 59
SP - 439
EP - 448
JO - European Journal of Pharmaceutics and Biopharmaceutics
JF - European Journal of Pharmaceutics and Biopharmaceutics
SN - 0939-6411
IS - 3
ER -
ID: 16756736